In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1309774-03-5, name is 7-Bromo-2-chloro-1,5-naphthyridine, introducing its new discovery. HPLC of Formula: C8H4BrClN2
A novel series of (7-aryl-1,5-naphthyridin-2-yl)ureas was discovered as dual ERK2 and Aurora B kinases inhibitors. Several analogues were active at micromolar and submicromolar range against ERK2 and Aurora B, associated with very promising antiproliferative activity toward various cancer cell lines. Synthesis, structure activity relationship and docking study are reported. In vitro ADME properties and safety data are also discussed.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1309774-03-5, and how the biochemistry of the body works.HPLC of Formula: C8H4BrClN2
Reference£º
1,658-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N652 – PubChem